Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06532253
PHASE1/PHASE2
Long-term Safety Trial with NVDX3
Sponsor: Novadip Biosciences
View on ClinicalTrials.gov
Summary
An study evaluating the long-term safety of all patients previously treated with NVDX3.
Official title: Long-term Safety Bucket Trial with NVDX3, an Osteogenic Implant of Human Allogenic Origin.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2024-08-22
Completion Date
2036-03
Last Updated
2024-09-05
Healthy Volunteers
No
Interventions
DRUG
NVDX3
NVDX3 is implanted during a single surgical intervention, that took place in the core trials (refer to NCT05961956 and NCT05987033)
Locations (1)
Centre Hospitalier de Luxembourg
Luxembourg, Luxembourg